|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
82,460,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile PAVmed is a medical technology company organized to advance a pipeline of medical technologies from concept to commercialization. Co.'s EsoGuard and EsoCheck have been developed to provide a screening test for the early detection of adenocarcinoma of the esophagus (EAC) and Barrett's Esophagus (BE), including dysplastic BE and related pre-cursors to EAC in patients with chronic gastroesophageal reflux. Co.'s EsoCure is in development as an Esophageal Ablation Device, with the intent to allow a clinician to treat dysplastic BE before it can progress to EAC, a lethal esophageal cancer. Co.'s CarpX is a minimally invasive surgical device for use in the treatment of carpal tunnel syndrome.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
250,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$161,008 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
3 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Pavilion Venture Partners Llc |
Chairman and CEO |
|
2019-05-23 |
4 |
B |
$1.10 |
$32,850 |
D/D |
30,000 |
848,413 |
2.37 |
- |
|
Pavilion Venture Partners Llc |
Chairman and CEO |
|
2019-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
818,413 |
|
- |
|
Mcgrath Dennis M |
EVP & CFO |
|
2019-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
500,000 |
524,000 |
|
- |
|
Sirovich Matthew |
10% Owner |
|
2018-12-27 |
4 |
A |
$0.00 |
$0 |
I/I |
60,000 |
792,000 |
|
- |
|
Sirovich Matthew |
10% Owner |
|
2018-12-27 |
4 |
A |
$0.00 |
$0 |
D/D |
272,400 |
738,914 |
|
- |
|
Pavilion Venture Partners Llc |
Chairman and CEO |
|
2018-08-28 |
4 |
B |
$1.18 |
$35,400 |
D/D |
30,000 |
618,413 |
2.37 |
- |
|
Pavilion Venture Partners Llc |
Chairman and CEO |
|
2018-06-12 |
4 |
OE |
$0.00 |
$0 |
I/I |
1,998 |
2,280 |
|
- |
|
Greenspan Ira Scott |
10% Owner |
|
2018-06-08 |
4 |
S |
$1.04 |
$19,032 |
D/D |
(18,300) |
421,691 |
|
- |
|
Greenspan Ira Scott |
10% Owner |
|
2018-06-01 |
4 |
S |
$0.97 |
$516,287 |
D/D |
(532,255) |
439,991 |
|
- |
|
Pavilion Venture Partners Llc |
Chairman and CEO |
|
2018-02-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
34,153 |
588,413 |
|
- |
|
Deguzman Brian J. |
Chief Medical Officer |
|
2017-12-21 |
4 |
D |
$0.00 |
$0 |
I/I |
(645,346) |
0 |
|
- |
|
Deguzman Brian J. |
Chief Medical Officer |
|
2017-12-21 |
4 |
A |
$0.00 |
$0 |
I/I |
645,346 |
645,346 |
|
- |
|
Glennon Michael J |
Vice Chairman |
|
2017-12-21 |
4 |
D |
$0.00 |
$0 |
I/I |
(645,346) |
0 |
|
- |
|
Glennon Michael J |
Vice Chairman |
|
2017-12-21 |
4 |
A |
$0.00 |
$0 |
I/I |
645,346 |
645,346 |
|
- |
|
Pavilion Venture Partners Llc |
Chairman and CEO |
|
2017-11-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(67,317) |
5,646,562 |
|
- |
|
Greenspan Ira Scott |
Director |
|
2017-11-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(67,317) |
5,646,562 |
|
- |
|
Pavilion Venture Partners Llc |
Chairman and CEO |
|
2017-11-21 |
4 |
A |
$4.30 |
$5,160 |
D/D |
1,200 |
71,489 |
|
- |
|
Pavilion Venture Partners Llc |
Chairman and CEO |
|
2017-11-20 |
4 |
B |
$0.00 |
$0 |
D/D |
950 |
70,289 |
2.37 |
- |
|
Pavilion Venture Partners Llc |
Chairman and CEO |
|
2017-11-17 |
4 |
B |
$0.00 |
$0 |
D/D |
601 |
69,339 |
2.37 |
- |
|
Pavilion Venture Partners Llc |
Chairman and CEO |
|
2017-09-15 |
4 |
B |
$0.00 |
$0 |
D/D |
2,600 |
68,738 |
2.37 |
- |
|
Pavilion Venture Partners Llc |
Chairman and CEO |
|
2017-09-13 |
4 |
B |
$0.00 |
$0 |
D/D |
300 |
66,138 |
2.37 |
- |
|
Pavilion Venture Partners Llc |
Chairman and CEO |
|
2017-09-12 |
4 |
B |
$6.66 |
$666 |
D/D |
100 |
65,838 |
2.37 |
- |
|
Pavilion Venture Partners Llc |
Chairman and CEO |
|
2017-09-11 |
4 |
B |
$0.00 |
$0 |
D/D |
300 |
65,738 |
2.37 |
- |
|
Pavilion Venture Partners Llc |
Chairman and CEO |
|
2017-09-08 |
4 |
B |
$0.00 |
$0 |
D/D |
400 |
65,438 |
2.37 |
- |
|
Pavilion Venture Partners Llc |
Chairman and CEO |
|
2017-09-07 |
4 |
B |
$0.00 |
$0 |
D/D |
850 |
65,038 |
2.37 |
- |
|
104 Records found
|
|
Page 2 of 5 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|